Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
EnviroGold Closes Upsized Unit Offering Raising $4.1M and Announces New Director (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Harmony Biosciences Holdings Inc HRMY

Healthcare Biotechnology
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company. It is focused on developing and commercializing therapies for patients living with rare neurological diseases as well as patients living with other neurological diseases who have unmet medical needs. Its product, WAKIX (pitolisant), is a first-in-class molecule with a novel mechanism of action designed to enhance... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:HRMY)

Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts

Business Wire 3 days ago

Levi & Korsinsky Announces an Investigation on Behalf of Harmony Biosciences Holdings, Inc. (HRMY) Shareholders Who May Have Been Affected by Fraud

Accesswire December 20, 2024

Lost Money on Harmony Biosciences Holdings, Inc.(HRMY)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

Accesswire December 19, 2024

HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

PR Newswire December 18, 2024

Lost Money on Harmony Biosciences Holdings, Inc.(HRMY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

Accesswire December 18, 2024

Investors who lost money on Harmony Biosciences Holdings, Inc. should contact Levi & Korsinsky about an ongoing investigation - HRMY

Accesswire December 17, 2024

Harmony Biosciences Holdings, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - HRMY

Accesswire December 16, 2024

HRMY ALERT - Levi & Korsinsky Has Commenced an Investigation on Behalf of Harmony Biosciences Holdings, Inc. Shareholders Who Lost Money

Accesswire December 13, 2024

Harmony Biosciences Holdings, Inc. Being Investigated on Behalf of Harmony Biosciences Holdings, Inc. Investors. Contact Levi & Korsinsky For Details.

Accesswire December 12, 2024
View More News ››

Opinion & Analysis (NDAQ:HRMY)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:HRMY)

HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANC

NEWS: $HRMY HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE...
whytestocks - October 29, 2024

Harmony Biosciences Reports Strong Second Quarter 2024 Finan

NEWS: $HRMY Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward...
whytestocks - August 6, 2024

Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Ad

News; $HRMY Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of...
whytestocks - April 30, 2024

PITOLISANT IS A “PORTFOLIO IN A PRODUCT” OPPORTUNITY!

Harmony Biosciences, Inc. (NASDAQ: HRMY) is a commercial-stage biopharmaceutical company developing novel therapeutics for rare and...
AviseAnalytics - June 2, 2022
View more Bullboard ››

NurExone Biologic Inc.

NurExone Biologic Inc.

NurExone Biologic Inc. is a pharmaceutical company. The Company is engaged in developing a platform for biologically guided ...
View More »